US pharmacy pricing
Vabysmo Prices at US Pharmacies
Lowest price found · US pharmacies
$2,431.10/fill
for Vabysmo, across the pharmacies in our data
US pharmacy prices — 1ml of 6mg/0.05ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $2,431.10Lowest | $2,434.10 | $2,886.67 | |
| $2,431.10Lowest | $2,434.10 | $2,886.67 | |
| $2,552.07 | $2,555.07 | $2,886.67 | |
| $2,568.22 | $2,571.22 | $2,886.67 | |
| $2,624.83 | $2,627.83 | $2,886.67 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Vabysmo.
Frequently asked questions
Is Vabysmo (Vabysmo) expensive if I don't have insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Vabysmo is around $2,431.10. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Vabysmo available?
Generic and brand-name pricing for Vabysmo is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How much does Vabysmo cost with insurance?
The cost of Vabysmo with insurance is highly variable and depends on the specific details of your health plan. Factors include whether the medication is on your plan's formulary, your deductible status, and your co-pay or coinsurance requirements. You should contact your insurance provider directly for precise information on coverage and your expected share of the cost. If your plan does not cover Vabysmo, or if you have Medicare or Medicaid, investigating alternative savings programs could be beneficial. Comparing the price available through these programs with your insurance co-pay can help you find the most affordable option.
Is generic Vabysmo available?
Vabysmo (faricimab) is a brand-name medication developed by Genentech. As of now, no generic (bioequivalent) version of Vabysmo has been approved for sale in the United States.